A Genetically Determined Dose–Volume Histogram Predicts for Rectal Bleeding among Patients Treated With Prostate Brachytherapy
- 1 August 2007
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 68 (5), 1410-1416
- https://doi.org/10.1016/j.ijrobp.2007.02.052
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Long-Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate CancerJournal of Urology, 2006
- Disease-specific survival following the brachytherapy management of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Predictors of Prostate Cancer–Specific Mortality After Radical Prostatectomy or Radiation TherapyJournal of Clinical Oncology, 2005
- Effects of radiation on normal tissue: consequences and mechanismsThe Lancet Oncology, 2003
- Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinomaCancer, 1999
- Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effectInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Patient-to-patient variability in the expression of radiation-induced normal tissue injurySeminars in Radiation Oncology, 1994
- Probability of radiation‐induced complications for normal tissues with parallel architecture subject to non‐uniform irradiationMedical Physics, 1993
- Correlation of radiotherapeutic parameters and treatment related morbidity—analysis of RTOG study 77-06International Journal of Radiation Oncology*Biology*Physics, 1987